Company Overview

Update
Founded:
2007
Founders:
Mike Clayman, Neil Bodick
Headquarters:
Woburn, MA
IPO:
Went Public
Stock:
NASDAQ:FLXN
Categories:
Biotechnology

Flexion Therapeutics is a biotechnology company that develops long-lasting intra-articular injection therapies to treat osteoarthritis.

Description

Update

Flexion Therapeutics advances drug candidates through clinical proof of concept and beyond, in partnership with pharmaceutical and biotechnology companies. By providing expertise and sharing risk, Flexion effectively expands the portfolios of its partners.

Current Team (9)

Update

Board Members and Advisors (7)

Update

Funding Rounds (3) - $107M

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    300 TradeCenter

    Suite 2460

    Woburn, MA 01801

    USA

Images (1)

Update
  • D50111fd8fad89bd57652d2447b7fba6